[1] 陆承平.兽医微生物学[M].北京:中国农业出版社,2013. [2] 中国兽药典委员会编.中华人民共和国兽药典二○一○年版三部[S].北京:中国农业出版社,2011. [3] Saint-Joanis B,Garnier T,Cole S T.Gene cloning shows the α-toxin of Clostridium perfringens to contain both sphingomyelinase and lecithinase activities[J].Mol Gen Genet,1989,219(3):453-460. [4] 农业部兽用生物制品规程委员会.中华人民共和国兽用生物制品规程二○○○版[S].北京:化学工业出版社,2000. [5] Rood J I.Virulence genes of Clostridium perfringens[J].Annu Rev Microbial,1998,52:333-360. [6] Pietro B,Andrea D P,Silvia S,et al.Toxin genotyping of Clostridium perfringens strains using a polymerase chain reaction protocol[J].Veterinaria Italiana,2010,46(1):113-118. [7] Ferrarezi M C,Cardoso T C,Dutra I S.Genotyping of Clostridium perfringens isolated from calves with neonatal diarrhea[J]. Anaerobe,2008,14(6):328-331. [8] 郑晓丽,窦贤明,胡道俊,等.产气荚膜梭菌对养牛业的危害及防制[J].中国畜牧兽医,2010,37(8):211-214. [9] 王海荣,王磊,姜世金,等.不同方法对牛舍气载魏氏梭菌型别的研究[J].家畜生态学报,2006,27(2):76-79. [10] McClane B A,Doyle M P,Beuchat L R,et al.Food microbiology:Fundamentals and frontiers[M].2nd ed.Washington DC:ASM Press,2001. [11] Animal and Plant Health Inspection Service,USDA.9 CFR Ch.I(1-1-07 Edition)[S].Washington:US Government Printing Office,2007. [12] British Pharmacopoeia Commission.British pharmacopoeia (veterinary) [M].London:The Stationery Office,2005. |